Can’t reject Medical Reimbursement Claim only because patient was treated in a non-network hospital: Madras HC

Madurai: The Madurai bench of Madras High Court recently reiterated that a claim for medical reimbursement cannot be rejected merely because the treatment was undertaken in a non-networking hospital.

“The issues regarding the settlement of the medical claim are no more res-integra in respect of the treatment undertaken in a non-network hospital. Several orders have been passed by the Courts to settle the medical reimbursement claim and not to reject the same merely on the ground that the hospital is not falling under the list of network hospitals,” noted the HC bench comprising Justices SM Subramaniam and V Lakshminarayanan.

Such observations were made by the HC bench while considering a plea challenging the order of rejection to settle the medical reimbursement claim of the petitioner issued by the Director of Health and Rural Services.

The petitioner, a State pensioner, is a member of the Medical Health Scheme. He held the post of Chief Administrative Officer in the Principal District Court, Pudukkottai and consequently retired from the post in 2010. He regularly pays the subscription fees under the Medical Health Scheme.

While undergoing surgery for a left renal tumour (Cancer), the petitioner was admitted as an in-patient at BRS Hospital, Chennai. During his stay at the hospital, he spent a sum of Rs 1,24,576 towards medical expenses.

Following this, he submitted an application seeking medical reimbursement. However, his petition for medical claim reimbursement was rejected by the Director of Health and Rural Services on the ground that he undertook treatment in a non-network hospital. Referring to this, the authorities held him ineligible for medical reimbursement claim.

Also Read: AYUSH treatment on par with Allopathic treatment for Reimbursements: HC

Challenging this order, the petitioner approached the High Court bench and demanded reimbursement for the money he spent on his treatment. On the other hand, the counsel for the Government submitted that the medical claim will be settled only in the event of taking treatment in a network hospital. The counsel further pointed out that the hospital, in which the petitioner was treated, is not a network hospital, and therefore, the rejection was in order.

However, the court referred to several orders passed by the Courts and pointed out,

“Several orders have been passed by the Courts to settle the medical reimbursement claim and not to reject the same merely on the ground that the hospital is not falling under the list of network hospitals.”

In respect of the petitioner’s case, the bench noted that there was no dispute in the genunity of the treatment taken by the petitioner. The bench further observed,

“In the present case, the genunity of the treatment taken by the petitioner has not been disputed. Once the treatment is found to be genuine, there is no reason to reject the medical claim of the petitioner.”

With this observation, the bench issued direction to the government authorities to settle the claim for medical reimbursement. The order stated, “In view of the facts and circumstances, the impugned order passed by the 2nd respondent dated 02.04.2018 is set aside. The 7th respondent is directed to settle the eligible medical reimbursement claim of the petitioner under the scheme within a period of six (6) weeks from the date of receipt of a copy of this order and the respondents 1 to 6 shall ensure that the payment is made by the 7th respondent within the time stipulated by us in this order.”

To view the order, click on the link below:

https://medicaldialogues.in/pdf_upload/madras-hc-medical-reimbursement-227700.pdf

Also Read: Hospital charging amounts exceeding approved rates, state can’t deny medical reimbursement

Powered by WPeMatico

KNRUHS issues notice for MBBS Students 2020-21 Batch who seek to Avail Additional Attempt Of First professional MBBS Exams, details

Telangana: Kaloji Narayana Rao University of Health Sciences (KNRUHS) has issued a notice for all the students of the 2020-21 batch who have completed four attempts of the First professional MBBS Examinations seeking to avail additional attempt (5th attempt) of First professional MBBS Examinations.

The university has asked all the students of the 2020-21 batch who have completed four attempts of the First professional MBBS Examinations and the parents concerned to contact the Principal of the college to avail additional attempt (5th attempt) of First professional MBBS Examinations.

As per the notice, an additional attempt (5th attempt) of First Professional MBBS Examinations will tentatively be scheduled for the month of February 2024. The students need to keep track of the official website of KNRUHS for further updates.

The notice states that “all the students of 2020-21 batch who have completed four attempts of First professional MBBS Examinations and the parents concerned are informed to contact the Principal of the college to avail additional attempt (5th attempt) of First professional MBBS Examinations tentatively scheduled in the month of February 2024.”

The National Medical Commission, Under Graduate Medical Education Board, vide Public Notice No. U.13021/01/2023/UGMEB/, Dated:11.12.2023 decided to allow one additional attempt (5th attempt) to the MBBS Students who were admitted to medical colleges during the academic year 2020-21 and could not pass their First professional MBBS examination, as the said batch was also affected by COVID-19 Pandemic.

This is a one-time measure and may not be treated as a precedence for the future.

Kaloji Narayana Rao University of Health Sciences (KNRUHS) is a public university in the city of Warangal, Telangana. The university is named after its poet and political activist, Telangana Kaloji Narayana Rao. It was established after the formation of the State of Telangana by adopting the Dr NTR University of Health Sciences Act vide G.O.M s No. 20 HM&FW (Cl) Department Dated 26.09.2014 with headquarters at Warangal.

To view the notice, click on the link below –

https://medicaldialogues.in/pdf_upload/20231213104120knruhs-examinations-circular-permission-by-nmc-for-additional-attempt-5th-attempt-to-mbbs-2020-21-batch-in-first-professional-examinations-227869.pdf

Powered by WPeMatico

Arterial blood gas analysis must for detecting severe resting hypoxemia in COPD in addition to pulse oximetry

Chronic obstructive pulmonary disease (COPD) is globally the third leading cause of death, causing 3.23 million deaths in 2019.

Most feasible way to measure oxygen saturation is by pulse oximetry (SpO2). The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines recommend evaluation with arterial blood gas (ABG) analysis if SpO2 is ⩽92%.

This recommendation has not been evaluated in stable outpatients with COPD undergoing testing for Long-Term Oxygen Therapy (LTOT) to evaluate whether the performance of SpO2 compared with ABG analysis of PaO2 and arterial oxygen saturation (SaO2) to detect severe resting hypoxemia in patients with COPD a team of researchers conducted a study.

The study published in Annals of American Thoracic Society, reports that SpO2 alone may have a high false-negative (FN) rate for detecting severe resting hypoxemia in COPD patients being assessed for long-term oxygen therapy (LTOT). The GOLD recommends reflex measurement of PaO2 through ABG analysis. This is crucial, particularly for active smokers, and it is advisable to use a cutoff higher than SpO2 ⩽92%.

Researchers conducted a Retrospective analysis of paired SpO2 and ABG values from stable outpatients with COPD who underwent LTOT assessment in a single center. They calculated false negatives (FNs) as an SpO2 >88% or >89% in the presence of pulmonary hypertension with a PaO2 ⩽55 mm Hg or ⩽59 mm Hg in the presence of pulmonary hypertension. Test performance was assessed using receiver operating characteristic (ROC) analysis, intraclass correlation coefficient (ICC), test bias, precision, and accuracy root-mean-square (Arms). An adjusted multivariate analysis was used to evaluate factors affecting SpO2 bias.

The key findings of the study are

• A total of 518 patients were included, the prevalence of severe resting hypoxemia was 74 (14.3%), with 52 missed by SpO2 (FN, 10%), including 13 (2.5%) with an SpO2 > 92% (occult hypoxemia).

• FNs and occult hypoxemia in Black patients were 9% and 1.5%, respectively, and were 13% and 5%, respectively, among active smokers.

• The correlation between SpO2 and SaO2 was acceptable (ICC = 0.78; 95% confidence interval, 0.74–0.81); and the bias of SpO2 was 0.45%, with a precision of 2.6 (−4.65 to +5.55%) and Arms of 2.59.

• These measurements were similar in Black patients, but in active smokers, correlation was lower and bias showed greater overestimation of SpO2.

• ROC analysis suggests that the optimal SpO2 cutoff to warrant LTOT evaluation by ABG analysis is ⩽94%.

In conclusion, “SpO2 as the only measure of oxygenation carries a high FN rate in detecting severe resting hypoxemia in patients with COPD undergoing evaluation for LTOT. Reflex measurement of PaO2 by ABG analysis should be used as recommended by GOLD, ideally at a cutoff higher than an SpO2 ⩽92%, especially in active smokers.”

Reference: Brian Garnet , Rodrigo Diaz-Lankenau , Elie Jean et al ; Accuracy of Pulse Oximetry for Long-Term Oxygen Therapy Assessment in Chronic Obstructive Pulmonary Disease; Ann. Of Am. Thor. Soc. DOI:https://doi.org/10.1513/AnnalsATS.202209-837OC

Powered by WPeMatico

Construction of AIIMS Rewari set to commence soon: Haryana Health Minister Anil Vij

Chandigarh: Haryana’s Health Minister Anil Vij  said the work for construction of All India Institute of Medical Sciences (AIIMS), Rewari is expected to start shortly.

Responding to a question raised during the Question Hour in the state Assembly by Congress’ Rewari MLA Chiranjeev Rao, Vij emphasised that the Haryana government, in its commitment to strengthening healthcare infrastructure, has acquired over 203 acres of land at the rate of Rs 40 lakh per acre.

The land has been leased to the Union Ministry of Health and Family Welfare to construct AIIMS in Rewari, he said.

Also Read:PM Modi to soon lay foundation stone of AIIMS Rewari: Haryana Minister

He said the state government is committed to advancing healthcare facilities in the region.

Congress member B B Batra raised a question seeking to know the number of unauthorised colonies which existed in 2014, the number of unauthorised colonies regularised from 2005 to 2014 and the number of such colonies which came into existence from 2014 to 2023.

He also sought to know the number of FIRs registered in respect of unauthorised colonies and the number of unauthorised colonies demolished from 2014 to 2023.

In reply, Chief Minister M L Khattar informed the House that a total of 11,665 unauthorised colonies existed on record as of December 31, 2014.

He said 887 unauthorised colonies were regularised from the year 2005 to 2014 by the Department of Urban Local Bodies.

As many as 5,352 unauthorised colonies were detected from January 1, 2015, to November 30, 2023.

From 2015 to 2023, unauthorised colonies regularised include 1,089 by the Department of Urban Local Bodies and 448 by the Department of Town and Country Planning.

As many as 1,789 FIRs were registered against unauthorised colonies during January 1, 2015 to November 30, 2023, the House was informed. As many as 3,500 unauthorised colonies were demolished during this period.

Responding to another question raised in the House, Deputy Chief Minister Dushyant Chautala informed that a proposal to establish an Industrial Model Township near the intersection of NH-152D and the Delhi-Katra Expressway in Jind district is under consideration.

Chautala further said that two potential sites in Jind have been identified, and the land acquisition process has been initiated.

During the Zero Hour, Congress members staged a brief walkout from the House after Leader of Opposition Bhupinder Singh Hooda said his party’s adjournment motion on recent deaths due to spurious liquor in Yamunanagar and Ambala districts was not allowed.

However, the Congress members were informed by the Chair that the matter would be taken up as ‘Calling Attention’ as some members had given notice in this regard.

Meanwhile, replying to a calling attention motion in the Vidhan Sabha, Chautala said since its launch in March 2016, the Pradhan Mantri Fasal Bima Yojana has been meticulously aligned with the Government of India’s guidelines.

It provides crucial insurance coverage for key crops like paddy, bajra, maize, cotton, and moong in the Kharif season, and wheat, mustard, gram, barley, and sunflower in the Rabi season.

On the issue of crop loss due to floods and heavy rains earlier this year, he said that claims worth Rs 65.18 crore have already been disbursed to 35,365 farmers.

Powered by WPeMatico

Karnataka directs 2017 Batch medicos to Join compulsory Rural Service

Bengaluru: The State Government authorities of Karnataka have asked the medical graduates from the 2017 batch, who completed their MBBS course from government-quota seats, to join the one-year compulsory rural service. 

Many of these students are either busy with work or pursuing higher studies. However, as per the rules, if any student does not fulfill the rural service requirements will be slapped with a Rs 10-lakh penalty.

Around 4,170 students are eligible to attend the counselling for rural services this year. TOI adds that for the first time, the State has allowed merit-based exemptions for students based on their MBBS scores.

A notification in this regard has been issued on December 11. The concerned notification is applicable for the MBBS students who were admitted in Government medical colleges and under the government quota seats in private medical institutes during the academic year 2017-2018. Consequently, they graduated after completing their internship in the year 2023.

Also Read: Karnataka Govt proposes restricting compulsory service only for GMC graduates

As per the latest media report by the Times of India, several students are upset over the delayed posting for compulsory rural service. However, the officials in the Health and Family Welfare Department have claimed that the delay was caused because of an amendment that was brought in recently. 

Earlier this year, in October, the State Government announced that rural service rules would be relaxed to the extent of staff availability in the hospitals. Referring to this, an official from the State Health Department informed TOI, “Initially, we did not have enough posts for all students. Then, the amendment to the compulsory service law had to be brought in to restrict the number of students depending upon the posts. The notification was issued as soon as the amendment was made.”

The Daily adds that the notification that was issued under the Karnataka Compulsory Selection of Candidates for Admission to Government Seats in Professional Education Institutions Rules 2006 mentioned that to fill up the available vacancies, online counselling will be held. For the first time, merit-based exemptions will be made applicable for rural service.

Therefore, this year, the candidates who will appear in the counselling for the rural service will have the flexibility to either select a preferred location for one year of service or apply for a merit-based exemption from the same.

Following this, the online counselling system will allocate either the exemption or the location, based on the merit of the candidate. This shall be done based on the MBBS scores provided by the Rajiv Gandhi University of Health Sciences to the department. Therefore, students who have high ranks will get the first chance of getting an exemption.

The MBBS students will have 198 options regarding the preferred service location. Those candidates, who will not register for the online counselling process or who will fail to report to duty will have to pay a penalty of Rs 10 lakh. 

Generally, the exemptions are for students admitted to NMC/RGUHS-approved higher courses and who must undergo one-year compulsory service in a government hospital after completing their PG/DNB/fellowships. Apart from them, women on maternity leave will get a late-commencement exemption for up to one year.

Medical Dialogues had previously reported that earlier this month, the Karnataka Government introduced a bill specifically aiming to replace an ordinance that eliminates the mandatory one-year rural service requirement for medical college graduates in the state.

The bill, tabled by Health Minister Dinesh Gundu Rao, proposes amendments to sections 3, 4, and 5 of the Karnataka Compulsory Services by Candidates Completed Medical Courses Act, 2012.

According to the statement of objects and reasons provided in the bill, the amendment seeks to exempt candidates chosen for central or state government services from the obligation to serve in rural areas.

Previously, under the Karnataka Compulsory Service by Candidates Completed Medical Courses Act, all MBBS, postgraduate, and super-speciality graduates were required to spend one year working in government healthcare institutions in rural areas as junior residents.

Also Read: Proposal to eliminate compulsory rural service for medical graduates moved in Karnataka Assembly

Powered by WPeMatico

Pfizer concludes USD 43 billion acquisition of Seagen

New York: Pfizer Inc. has announced the successful completion of its acquisition of Seagen Inc., a global biotechnology company that discovers, develops and commercializes transformative cancer medicines. Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion.

“Cancer remains a leading cause of death, and one in three people in the U.S. will receive a cancer diagnosis in their lifetime. With one of the largest investments in Pfizer’s history, we are going all in on cancer with the goal of delivering breakthroughs that drastically improve the lives of people with cancer,” said Dr. Albert Bourla, Pfizer Chairman and Chief Executive Officer. “With Seagen’s proprietary, world-leading Antibody-Drug Conjugate (ADC) technology, together with the scale and strength of Pfizer’s capabilities and expertise, we are poised to change the cancer treatment paradigm. We believe Oncology will be a significant growth driver for Pfizer and contribute meaningfully to the achievement of our near- and long-term financial goals.”

With the addition of Seagen’s four in-line medicines, ADCETRIS (brentuximab vedotin), PADCEV (enfortumab vedotin), TIVDAK (tisotumab vedotin) and TUKYSA (tucatinib), Pfizer’s industry-leading Oncology portfolio now includes over 25 approved medicines and biosimilars across more than 40 indications, including nine medicines that are either blockbuster or have the potential to be blockbuster.

With the addition of Seagen, Pfizer’s Oncology pipeline has doubled in size with 60 programs spanning multiple modalities, including ADCs, small molecules, bispecifics and other immunotherapies. Moving forward, Pfizer will leverage its leading protein engineering and medicinal chemistry capabilities to advance Seagen’s ADC technology, unlocking potential novel combinations and next-generation biologics.

“This is a great day for Pfizer, and, more importantly, for people living with cancer, as we bring together the game-changing science and top talent of Seagen and Pfizer to form a leading Oncology organization,” said Chris Boshoff, Chief Oncology Officer and Executive Vice President, Pfizer. “Driven by science and a passion for improving and extending patients’ lives, together, we will work with urgency towards our common purpose to deliver transformative cancer medicines and bring new hope to people living with cancer everywhere.”

As previously disclosed, to address U.S. Federal Trade Commission concerns, Pfizer has chosen to irrevocably donate the rights of royalties from sales of Bavencio (avelumab) in the U.S. to the American Association for Cancer Research (AACR). This unrestricted donation will support AACR in its mission to prevent and cure cancer through research, education, communication, collaboration, science policy, and funding for cancer research.

Guggenheim Securities, LLC served as Pfizer’s financial advisor and Wachtell, Lipton, Rosen & Katz and Arnold & Porter Kaye Scholer LLP served as Pfizer’s legal advisors. Centerview Partners LLC served as Seagen’s financial advisor and Sullivan & Cromwell LLP served as Seagen’s legal advisor. MTS Health Partners also provided financial advice to Seagen.

Read also: Pfizer gains unconditional EU antitrust nod for proposed USD 43 billion Seagen acquisition

Powered by WPeMatico

AstraZeneca India, Roche Diagnostics India collaborate to improve diagnostic testing for breast cancer

Bengaluru: AstraZeneca Pharma India Ltd. has signed a memorandum of understanding (MoU) with Roche Diagnostics India to improve diagnostics for breast cancer patients with a key focus to streamlining HER2 diagnostics with newer advancements in the field.

Breast cancer, globally the most prevalent cancer among women, takes a critical turn when transitioning to metastatic stages, accounting for 30% of post-diagnosis cases and constituting a primary cause of breast cancer-related fatalities. Vital to patient care is the reassessment of biomarkers, specifically HER2, guiding crucial treatment decisions. The 15% to 20% of cases identified as HER2 positive present opportunities for targeted therapies, with advancements in HER2 testing continually optimizing its clinical application since the 1980s.

In 2020, it was estimated that breast cancer claims nearly 700,000 lives worldwide each year and that there would be over 2.2 million new cases. Approximately half of all patients with breast cancer (mBC) express low levels of HER2. These patients with HER2 low status may now be eligible for a targeted treatment, which could significantly improve their outcomes.

Dr. Anil Kukreja, Vice President – Medical Affairs and Regulatory, AstraZeneca India, “AstraZeneca’s ambition is to be the leading company in breast cancer and contribute to the elimination of breast cancer as a cause of death. We are therefore, actively partnering with key stakeholders to put breast cancer at the forefront, to help improve standards of care. Our collaboration with Roche Diagnostics is a pivotal step, focusing on improving patient outcomes with emphasis on patient-centricity. We believe this strategic partnership contributes significantly towards creating an integrated healthcare ecosystem that strongly benefits the overall patient experience.”

The initiative is focussed on advancements in HER2 testing standardisation and reporting. As per the partnership, comprehensive training initiatives for pathologists and medical oncologists will be imparted. Training modules designed for oncologists will cover advances in HER-2 testing and HER-2 low interpretations.

Dr Rishubh Gupta, MD, Roche Diagnostics India and Neighbouring Markets shared, “Targeting and treating HER2-low breast cancer, which represents at least 55 percent of breast cancers globally, has been a challenge to the medical and scientific community. Earlier, metastatic breast cancer patients with a low level of HER2 status were considered to be part of the HER2-negative population and had no HER2-targeted treatment options. With this partnership, we bring hope to such patients and lead the way in HER2 diagnostics that supports the identification of patients who may benefit from HER2-targeted therapies.”

“This strategic alliance aligns with AstraZeneca’s commitment to advancing patient-centric healthcare solutions and Roche Diagnostics’ dedication to pioneering diagnostic innovation. The collaboration aims to address existing diagnostic challenges, reduce turnaround times, and elevate the overall patient experience, reinforcing the pivotal role of diagnostics in shaping effective treatment strategies for metastatic breast cancer patients in India,” the release stated.

Powered by WPeMatico

SGPGI lucknow to start tele-ICU service from 2024

Lucknow: The Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS) here will start its tele-ICU service from January 2024.

Director Prof R.K. Dhiman said that this would enable the institute to run 10 ICU beds, each through the hub and spoke model.

The step has been taken in wake of shortage of ICU beds at SGPGI so that their institute-like care can be provided to patients in these mentee medical colleges.

Also Read:Doctors at SGPGIMS ensure successful pregnancy, delivery in paroxysmal nocturnal haemoglobinuria patient

The director informed that the institute has been ranked as the third best among government medical education and patient care centres, but stressed on the need to strive for the top slot.

He also informed that the institute was working for the NAAC and NIRF accreditations besides promoting a culture of research.

He said that the next calendar year will see a number of new initiatives taking shape.

Listing out some of them, he said: “Five new departments have been approved for us – hepatology, medical oncology, infectious diseases, head and neck surgery and paediatric endocrinology, besides, the advanced paediatric centre and advanced diabetes centres are also in the pipeline.”

Stating that the institute had scaled significant heights in robotic surgery, he informed that they were in the process of procuring a gamma knife that can treat several cancerous and benign lesions.

He urged the government to help the institute on the count besides stressing on the need for a public health centre and department of clinical pharmacology so that awareness activities and clinical trials may be carried out.

Powered by WPeMatico

Foreign medical graduates in Himachal Pradesh await internship allotment

Solan: Despite clearing the Foreign Medical Graduate Examination (FMGE) in July of this year, Foreign Medical Graduates in the state are facing delays in the internship allotment process.

The state has eight medical colleges located in Shimla, Tanda, Hamirpur, Nahan, Mandi, Chamba, Bilaspur, and Solan and the FMGs are eagerly waiting to join the mandatory internship programme which is a must for practising in India.

FMGs in the state are facing delays even though some states like Gujarat, Tamil Nadu, and Jharkhand have already initiated their counselling schedules, with the process expected to conclude by the end of the month.

Also read- More Than 400 FMGs In Tamil Nadu Waiting To Join Internship, Urge Health Ministry To Expedite Allotment Process

The graduates argue that since they have already passed the screening test, they have proven their worth and should be allowed to avail internship opportunities as soon as possible.

“As per the NMC existing policy, 7.5 per cent of seats are reserved for foreign medical graduates and as per the guidelines, they will be asked to apply when the internship starts in January,” Dr Vinod Kashyap, Registrar of State Medical Council told The Tribune

Some states, such as Gujarat and Jharkhand, have released seat matrices and started the internship process for FMGs in November. However, FMGs in this particular state are still awaiting similar opportunities.

The FMGs in the state have not received any response from the State Medical Council, adding to the uncertainty and frustration among the graduates.

An FMG, Ajay Thakur, who recently met Health and Family Welfare Minister Dr Shandil here last week, told the daily, “I received my scorecard and passing certificate last month and am awaiting internship allocation in the medical colleges of the state.”

The graduates further added, “Some states such as Delhi were implementing policies that exclude students from other states from availing internships there. This has left the students hailing from the state with limited options but to seek internships from the medical colleges in the state.”

Recently, the National Medical Commission (NMC) has stated that Foreign Medical Graduates (FMG) who had a break in their final year and returned to India due to the Covid pandemic or the Russia-Ukraine war and have finished their coursework online, will be required to complete a mandatory one-year clinical clerkship. Afterwards, they will be eligible for the Compulsory Rotating Medical Internship (CRMI) or clinical medical rotatory internship.

Medical Dialogues team recently reported that the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has released several Frequently Asked Questions (FAQs) related to various issues concerning Foreign Medical Graduates (FMGs). 

Also read- NMC Releases FAQs Related To Issues Faced By Foreign Medical Graduates, Check Details

Powered by WPeMatico

Indian docs support WHO ban on vapes, call on govt to take action

New Delhi: A day after the World Health Organization (WHO) urged governments to treat e-cigarettes akin to tobacco and impose a ban on all flavours, health experts in India have called on the government to take immediate action.

The plea is coupled with an appeal to the nation’s youth to renounce smoking in all its forms.

While e-cigarettes, commonly known as vapes, have been considered by some as a potential tool in mitigating the adverse health effects associated with traditional smoking, the WHO contends that “urgent measures” are required to control the growing use of vapes.

Also Read:WHO calls for ban on flavoured vapes, treating e-cigarettes the same as tobacco

In India, a concerning trend has emerged with more 13-15-year-olds using vapes than adults, pointing to the aggressive marketing strategies employed to lure the younger demographic.

“Like other WHO countries, 13-15-year-olds and even adults are using vapes in India. Aggressive marketing of vapes has attracted the younger population more towards it. There are enough studies and sufficient evidence that vapes also create health problems affecting the lungs. It might help tobacco smokers quit, but they are harmful to health and could drive nicotine addiction among non-smokers, especially children and young people,” Dr. Col. Vijay Dutta, Internal Medicine & Pulmonologist, Indian Spinal Injuries Centre (ISIC), New Delhi, told IANS.

The experts emphasise that vapes cannot serve as a viable substitute for tobacco smoking.

The annual death toll of over 8.67 million attributed to tobacco use underscores the urgency of addressing this public health crisis.

“We cannot endorse the industry’s claim that vapes pose significantly lower health risks than tobacco. Youngsters are falling into the trap of using e-cigarettes early on and may become addicted to nicotine. Stringent measures are imperative, and a blanket ban could be the most effective solution. This includes bans on all flavouring agents, such as menthol, and applying tobacco control measures to vapes,” Dr. Soumya Mukherjee, Consultant, BMT, Haematology & Haemato Oncology at Narayana Hospital, Howrah told IANS.

The WHO said that while the long-term health risks of vapes remain unclear, they generate substances known to cause cancer, pose risks to heart and lung health, and could impact brain development in young people.

In India, where tobacco use is a leading risk factor for premature deaths, the urgency to address this issue is underscored by the experts who assert that tobacco use is among the unhealthy behaviours responsible for a preventable burden of cancers, strokes, and heart diseases.

“Nicotine and vaping products can have serious negative effects on the health of children and adolescents. Inhalation of nicotine through vaping can harm developing brains, impacting memory, attention, and impulse control. Nicotine is highly addictive, and early exposure increases the risk of lifelong addiction,” Dr Nehal Shah, Consultant Paediatrician, SRCC Hospital, Mumbai, told IANS.

Dr Shah said it is crucial to educate youth about the risks associated with nicotine and vaping, promoting awareness to prevent the initiation of these harmful habits and safeguard the well-being of future generations. Any kind of smoking is highly discouraged in kids and actions must be taken to quit smoking.

Powered by WPeMatico